Sectors

NEOG
Neogen Corporation
11.46
3 x 11.41
2 x 11.44
bid
ask
+
0.06
0.53%
09:38 AM
timesize
Ytd63.95%
1y124.27%
11.43
day range
11.63
5.11
52 week range
12.04
Open11.47Prev Close11.40Low11.43High11.63Mkt Cap2.49B
Vol50.16KAvg Vol2.36MEPS0.28P/E40.82Forward P/E30.18
Beta1.77Short Ratio5.43Inst. Own117.56%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning04-0950-d Avg9.72200-d Avg8.841yr Est13.00
Earning
DateForEstimateReportedSurprisesurprise %
2026-10-082026-080.05N/AN/AN/A
2026-07-302026-050.060.090.0358.81%
2026-04-092026-020.040.090.05125.00%
2026-01-082025-110.070.10.0342.86%
2025-10-092025-08-0.070.040.11154.05%
2025-07-292025-050.080.05-0.03-37.50%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-03Piper SandlerUpgradeNeutralNeutral
2026-01-12Piper SandlerUpgradeNeutralNeutral
2026-01-09GuggenheimUpgradeBuyBuy
2025-12-10CJS SecuritiesUpgradeMarket PerformMarket Outperform
2025-10-16Piper SandlerUpgradeNeutralNeutral
2025-09-29CJS SecuritiesUpgradeMarket Perform
Profile
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Insider Holder
DateNameRelationQuantityDescription
2025-10-26ADENT JOHN EDWARDFormer363.08KConversion of Exercise of derivative security
2025-10-26BOEHM WILLIAM TDirector47.91KConversion of Exercise of derivative security
2025-10-26BOREL JAMES C.Director94.57KConversion of Exercise of derivative security
2025-10-26JONES DOUGLAS EDWARDFormer100.88KConversion of Exercise of derivative security
2025-11-30NAEMURA DAVID HARTMANFormer90.39KConversion of Exercise of derivative security
2026-01-06RANALLI TAMARA AOfficer50.81KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Blackrock Inc.33.43M383.45M15.33%
2026-03-30Vanguard Portfolio Management LLC12.83M147.19M5.88%
2026-03-30T. Rowe Price Investment Management, Inc.10.16M116.57M4.66%
2026-03-30Vanguard Capital Management LLC9.57M109.71M4.39%
2026-06-29SG Americas Securities, LLC9.35M107.27M4.29%
2026-03-30Dimensional Fund Advisors LP9.13M104.74M4.19%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29iShares Trust-iShares Core S&P Small-Cap ETF13.12M150.48M6.02%
2026-06-29NEUBERGER BERMAN EQUITY FUNDS-Neuberger Genesis Fund7.79M89.32M3.57%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund6.90M79.17M3.17%
2026-06-29iShares Trust-iShares Russell 2000 ETF5.80M66.57M2.66%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund5.01M57.47M2.30%
2026-03-30BARON INVESTMENT Fd.S TRT -Baron Small Cap Fd.5.00M57.35M2.29%
Split
SplitDate
2 : 12021-06-07
2 : 12021-06-04
4 : 32018-01-02
4 : 32017-12-29
1.5 : 12013-10-31
1.5 : 12009-12-16